FOLVERLAN 0.4 mg tablets, 100 pcs

Instructions for use of Folverlan 0.4 mg

Folverlan 0.4 mg is a vitamin preparation that contains the active ingredient folic acid.It is used to prevent neural tube defects, particularly spina bifida ("open back"), as well as to prevent and treat folic acid deficiency conditions that cannot be corrected through diet.No prescription is required for this product.

Important notes

Folverlan 0.4 mg must not be taken if you are hypersensitive to folic acid or any of the other ingredients of the product.The preparation should also not be used if you have anemia caused by a vitamin B12 deficiency.Before taking it, it should be ensured that there is no megaloblastic anemia, which is due to a vitamin B12 deficiency.

Application and dosage

Always take Folverlan 0.4 mg exactly as directed in the package leaflet.To prevent neural tube defects, one tablet daily is recommended.To prevent folic acid deficiency, one or two tablets can be taken daily.To treat folic acid deficiency, two to three tablets can be taken three to four times a day.The tablets should be taken whole with a little liquid with meals.

Side effects

Like all medicines, Folverlan 0.4 mg can cause side effects, although not everyone gets them.In individual cases, hypersensitivity reactions such as skin redness, itching, shortness of breath, nausea or circulatory collapse can occur.At very high doses, gastrointestinal disorders, sleep disorders, agitation and depression can occur.

Storage

Store Folverlan 0.4 mg dry and not above 25°C.Store the medicine in the original packaging to protect the contents from moisture.Store drug out of reach of children.

Composition

The active ingredient is folic acid.One tablet contains 0.4 mg folic acid.The other ingredients are pregelatinized starch, lactose monohydrate, poly(O-carboxymethyl) starch sodium salt, microcrystalline cellulose, highly disperse silicon dioxide and magnesium stearate.

More information

Folverlan 0.4 mg does not contain gluten.They are small, round tablets with a longitudinal embossing and a pale yellow color.The package leaflet was last revised in September 2010.